Elanco Animal Health (ELAN) Gross Margin (2017 - 2026)

Elanco Animal Health (ELAN) reported Gross Margin of 57.26% for Q1 2026, down 8.0% on a YoY basis from 62.24% in Q1 2025, and up 11.21% sequentially from 51.49% in Q4 2025.

Elanco Animal Health (ELAN) Gross Margin (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Gross Margin data on file, last reported at 57.26% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 8.0% year-over-year to 57.26%; the trailing twelve-month figure through Mar 2026 stood at 55.06% (up 17.0% YoY), and the FY2025 full-year result was 54.99%, up 12.0% from the prior year.
  • Gross Margin grew to 57.26% in Q1 2026, from 51.49% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 60.7% in Q1 2023 to a low of 50.14% in Q4 2023.
  • A 5-year average of 55.62% and a median of 57.26% in 2026 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin jumped 402 bps in 2022 and slumped 437 bps in 2023, its largest moves.
  • Tracing ELAN's Gross Margin over 5 years: stood at 54.52% in 2022, then fell by 8 bps to 50.14% in 2023, then rose by 1 bps to 50.88% in 2024, then increased by 1 bps to 51.49% in 2025, then grew by 11 bps to 57.26% in 2026.
  • Business Quant data shows ELAN's Gross Margin at 57.26% in Q1 2026, 51.49% in Q4 2025, and 53.39% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 55.84%

Historic Data

Download Data
DateValue
Mar 31, 2026 57.26%
Dec 31, 2025 51.49%
Sep 30, 2025 53.39%
Jun 30, 2025 57.45%
Mar 31, 2025 57.33%
Dec 31, 2024 50.88%
Sep 30, 2024 52.23%
Jun 30, 2024 58.19%
Mar 31, 2024 57.26%
Dec 31, 2023 50.14%
Sep 30, 2023 54.40%
Jun 30, 2023 58.94%
Mar 31, 2023 60.70%
Dec 31, 2022 54.52%
Sep 30, 2022 54.00%
Jun 30, 2022 58.81%
Mar 31, 2022 58.48%
Dec 31, 2021 54.14%
Sep 30, 2021 55.61%
Jun 30, 2021 56.89%